Bone mass in ankylosing spondylitis

Citation
E. Toussirot et D. Wendling, Bone mass in ankylosing spondylitis, CLIN EXP RH, 18(5), 2000, pp. S16-S20
Citations number
35
Categorie Soggetti
Rheumatology,"da verificare
Journal title
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
ISSN journal
0392856X → ACNP
Volume
18
Issue
5
Year of publication
2000
Supplement
21
Pages
S16 - S20
Database
ISI
SICI code
0392-856X(200009/10)18:5<S16:BMIAS>2.0.ZU;2-O
Abstract
Specific spine ossifications or syndesmophytes are considered to be a hallm ark of ankylosing spondylitis (AS) and to reflect a process of bone formati on. Conversely, AS patients may develop osteoporosis (OP), as suggested by radiographic studies, an increased frequency of the vertebral fracture rate and reduced bone mass. Dual energy X-ray absorptiometry measurements have clearly demonstrated decreased bone mineral density (BMD) at both the lumba r spine and femoral neck. However; for patients with advanced spinal change s, ossifications may yield normal or increased values for the lumbar spine BMD. Assessment of biochemical markers of bone metabolism have shown that b oth bone formation and resorption are involved, with enhanced urinary excre tion of markers of collagen breakdown inpatients with active disease and ra ised inflammatory parameters, and changes in the levels of some bone growth factors. The pathophysiology of this osteoporosis in AS mainly involves di sease activity and, very likely, inflammatory cytokines. Finally, vertebral fractures complicating this bone loss contribute to spine deformity in pat ients with AS.